|
|
Volumn 14, Issue 7, 1997, Pages 197-200
|
|
Possible immunological treatment for Type 1 diabetes in the 21st century
|
|
Author keywords
Autoantigens; BCG vaccination; Beta cells; Gene therapy; IDDM; Immunoregulation; Immunotherapy; Tolerance; Type 1 diabetes mellitus
|
|
Indexed keywords
AUTOANTIGEN;
AZATHIOPRINE;
BCG VACCINE;
CD4 ANTIGEN;
CD8 ANTIGEN;
CYCLOSPORIN;
CYTOKINE;
CYTOKINE ANTIBODY;
FREUND ADJUVANT;
GAMMA INTERFERON;
GLUTAMATE DECARBOXYLASE;
HEAT SHOCK PROTEIN;
IMMUNOSUPPRESSIVE AGENT;
INSULIN;
INTERFERON ANTIBODY;
INTERLEUKIN 10;
INTERLEUKIN 2;
INTERLEUKIN 4;
MAJOR HISTOCOMPATIBILITY ANTIGEN;
NICOTINAMIDE;
PREDNISONE;
RECEPTOR ANTIBODY;
T LYMPHOCYTE ANTIBODY;
T LYMPHOCYTE RECEPTOR;
TACROLIMUS;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL MODEL;
AUTOIMMUNE DISEASE;
BCG VACCINATION;
GENE THERAPY;
HUMAN;
IMMUNOREGULATION;
IMMUNOSUPPRESSIVE TREATMENT;
IMMUNOTHERAPY;
INSULIN DEPENDENT DIABETES MELLITUS;
INTRAVENOUS DRUG ADMINISTRATION;
MOUSE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PANCREAS ISLET BETA CELL;
RAT;
SHORT SURVEY;
SUBCUTANEOUS DRUG ADMINISTRATION;
T LYMPHOCYTE;
|
|
EID: 0031454663
PISSN: 13578170
EISSN: None
Source Type: Journal
DOI: 10.1002/pdi.1960140708 Document Type: Short Survey |
|
Times cited : (3)
|
|
References (37)
|
